Serum kallistatin as a marker of severity of liver fibrosis in cirrhosis: A cross-sectional observational study
Background: Liver cirrhosis is among the leading causes of morbidity and mortality worldwide. Although liver biopsy is the gold standard for the assessment of liver fibrosis in cirrhosis, it has its own limitations. Therefore, noninvasive methods to detect liver fibrosis are widely preferred. Howeve...
Main Authors: | Seetaram Singh Kularaj, Sudhir Kumar Verma, Vivek Kumar, Ajay Kumar Patwa, Shyam Chand Chaudhary, Satyendra Kumar Sonkar, Kamlesh Kumar Gupta, Virendra Atam, Sanjeev Kumar Verma, Vivek Bhosale, Shail Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=5;spage=2129;epage=2133;aulast=Kularaj |
Similar Items
-
Factors influencing serum chemerin and kallistatin concentrations in patients with alcohol-induced liver cirrhosis
by: Andrzej Prystupa, et al.
Published: (2019-03-01) -
Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis
by: Zhiyun Cheng, et al.
Published: (2015-05-01) -
Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
by: Yuyu Yao, et al.
Published: (2018-11-01) -
Kallistatin leads to cognition impairment via downregulating glutamine synthetase
by: Yanlan Long, et al.
Published: (2024-04-01) -
Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells
by: Fauziyya Muhammad, et al.
Published: (2020-05-01)